T. Rowe Price Associates’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-46,937
Closed -$30K 3263
2026
Q1
$30K Hold
46,937
﹤0.01% 3099
2025
Q4
$41K Hold
46,937
﹤0.01% 3052
2025
Q3
$64K Sell
46,937
-34,100
-42% -$51.6K ﹤0.01% 2986
2025
Q2
$128K Buy
81,037
+4,420
+6% +$8.24K ﹤0.01% 2842
2025
Q1
$203K Buy
76,617
+745
+1% +$2.99K ﹤0.01% 2625
2024
Q4
$322K Buy
75,872
+18,844
+33% +$72.6K ﹤0.01% 2479
2024
Q3
$190K Hold
57,028
﹤0.01% 2666
2024
Q2
$177K Buy
57,028
+9,812
+21% +$32.3K ﹤0.01% 2617
2024
Q1
$191K Buy
47,216
+11,174
+31% +$42.1K ﹤0.01% 2639
2023
Q4
$202K Buy
36,042
+1,849
+5% +$10.6K ﹤0.01% 2542
2023
Q3
$183K Buy
34,193
+973
+3% +$7.9K ﹤0.01% 2529
2023
Q2
$312K Buy
33,220
+17,603
+113% +$154K ﹤0.01% 2346
2023
Q1
$136K Buy
15,617
+1,174
+8% +$10.4K ﹤0.01% 2622
2022
Q4
$102K Buy
14,443
+1,638
+13% +$13.7K ﹤0.01% 2717
2022
Q3
$128K Buy
+12,805
New +$116K ﹤0.01% 2666

Other funds holding DCGO

T. Rowe Price Associates's DCGO Position: Q2 2026 in Review

T. Rowe Price Associates sold out of DocGo (DCGO) in Q2 2026, closing a stake of 46,937 shares — an estimated $30K sold.

T. Rowe Price Associates first reported a position in DCGO in Q3 2022 and held it in 15 quarters. The position peaked at $322K in Q4 2024. 118 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • T. Rowe Price Associates reported no remaining DocGo position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 46,937 DocGo shares in Q2 2026, an estimated $30K.
  • T. Rowe Price Associates first reported a position in DocGo in Q3 2022 and held it in 15 quarters.
  • T. Rowe Price Associates's DocGo position peaked at $322K in Q4 2024.
  • 118 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.